There are now eight FDA-approved ADCs for the treatment of cancer, including three with accelerated approval within the last year. Recently approved ADCs, as well as many of those in development, seek ...

Driven by the success of 14 approved antibody drug conjugates (ADCs) and a promising developmental pipeline, the field of ADCs has gained significant traction and are anticipated to capture a notable ...

Cancer has been one of the most persistent diseases modern medicine has faced. Treatments are often tricky to develop as doctors and researchers have to differentiate between healthy and cancerous ...

The 3rd Next-Generation Conjugates Summit (Boston | February 26-28, 2024) is the only event dedicated to showcasing conjugate drugs with novel payloads and formats, providing unrivalled access to 30+ ...

Antibody-drug conjugates are a new kind of targeted treatment for multiple myeloma. They deliver powerful cancer-killing drugs straight to myeloma cells, and they help your own immune system attack ...

Figure 1: Structures of drugs and mAb-drug conjugates. AE and MMAE are highly stable molecules. There were no signs of compound degradation after 16 d in buffered saline at 37 °C. Furthermore, there ...

LONDON, Sept. 7, 2023 /PRNewswire/ -- Roots Analysis has announced the addition of "Antibody Drug Conjugate Market (7 th Edition), 2023-2035" report to its list of offerings. Antibody drug conjugates ...